Proove Biosciences Acquires Algynomics

Algynomics, Inc. is a research stage pain diagnostics company. Algynomics platform and its patient cohorts provide researchers with prospective data to identify individuals at increased risk for the development of chronic pain, which will allow targeted preventive efforts, enhance patient stratification in clinical trials to identify treatment responders, produce more sensitive inclusion/exclusion criteria for trial enrollment, and develop algorithms to tailor treatment for pain, enhancing outcomes and reducing adverse effects.